Drug Database
AC

acellular pertussis vaccine (pertactin / 69kDa protein, SBL / Infanrix)

✓ Approved

GSK · · 疫苗

什么是 acellular pertussis vaccine?

acellular pertussis vaccine 是一种疫苗,由GSK研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名pertactin, 69kDa protein, SBL, Infanrix
公司GSK
药物类别疫苗
分子靶点, , , ,
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

作用机制

分子靶点

acellular pertussis vaccine 作用于 5 个分子靶点:

()
()
()
()
()
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

acellular pertussis vaccine 针对 3 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsDiphtheria✓ Approved
Infections and infestationsPertussis✓ Approved
Infections and infestationsTetanus✓ Approved

相关研究文献

PubMedChina CDC weekly2026-11-18

Childhood Immunization Schedule for National Immunization Program Vaccines, China (Version 2026).

Administration National Disease Control And Prevention NDCAP, China National Health Commission Of The People's Republic Of NHCOTPRO

In June 2026, the National Disease Control and Prevention Administration and the National Health Commission issued the Childhood Immunization Schedule for National Immunization Program Vaccines (Version 2026). Compared with the 2021 version, the key updates include optimization of the five-dose Diphtheria-Tetanus-acellular Pertussis vaccine schedule (with the first dose advanced to 2 months of age and the fifth dose administered at 6 years of age); inclusion of the bivalent human papillomavirus vaccine in the National Immunization Program as a two-dose series for girls aged 13 years (Table 1); and expanded and refined vaccination guidance for children with medical conditions, including preterm and low-birthweight infants, children with allergies, children born to mothers living with human immunodeficiency virus, children with immune function abnormalities, jaundice, common congenital diseases, or common neurological diseases, and children receiving blood products. This English translation provides a reference for public health professionals.

PMID 43047791
阅读全文 →
PubMedCureus2026-11-18

Maternal Vaccine Receipt, Intentions, and Refusal Among Pregnant Women Attending Antenatal Care in Panama City: A Cross-Sectional Study.

Lucas Quintero Ana A, DeAntonio Rodrigo R, Escobar Luis L, Flores Luis Alberto LA et al.

Background/objectives Maternal vaccination surveys often combine willingness and receipt, potentially obscuring differences between these measures. We quantified self-reported vaccine receipt, intention without receipt, complete reported receipt, and refusal in an urban Panamanian convenience sample and examined their relationship with vaccination recommendation. Methods We analyzed an anonymous cross-sectional survey completed from March 26 to July 25, 2026, by 204 pregnant women aged 18 years or older recruited in health-related settings in Panama City. Self-reported receipt meant reporting at least one maternal vaccine during the current pregnancy. Intention without receipt meant planning at least one vaccine without reporting receipt of any specific vaccine. Complete reported receipt was the independent response "already received all," rather than verified completion of a vaccination schedule. Modified Poisson regression with robust variance estimated prevalence ratios (PRs). A secondary, post hoc evaluation examined six rating items without claiming formal questionnaire validation. Results The number of women who chose self-reported receipt was 128/204 (62.7%; exact 95% confidence interval (CI), 55.7-69.4), while the composite of receipt or intention was 190/204 (93.1%). Intention without receipt was reported by 62/204 (30.4%), complete reported receipt by 41/204 (20.1%), and refusal with coexisting receipt or intention by 92/204 (45.1%). Four participants reporting complete receipt did not report any vaccine-specific receipt. Refusal was reported for COVID-19 by 96/204 (47.1%), influenza by 11/204 (5.4%), tetanus, diphtheria, and acellular pertussis (Tdap) by 8/204 (3.9%), and respiratory syncytial virus (RSV) by 7/204 (3.4%). Receipt was reported by 126/172 (73.3%) participants with a vaccination recommendation versus 2/32 (6.2%) without one (adjusted PR, 11.28; 95% CI, 2.95-43.17). Three-item standardized Cronbach's alpha values were 0.699 and 0.728, with substantial ceiling effects and an unstable two-factor solution. Conclusions In this convenience sample, stated acceptance coexisted with the absence of reported receipt and vaccine-specific refusal. Recommendation was associated with receipt, but the estimate was imprecise and noncausal. These findings are not population estimates and support reporting recommendation, intention, receipt, and refusal separately. Intention without receipt does not establish subsequent failure to vaccinate.

PMID 43048589
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Vascular Complication Following Injection of Particulated Human Acellular Dermal Matrix: A Case Report.

Sung Sin Woo SW, Lee So Young SY, Seok Joon J, Kim Beom Joon BJ

PMID 43047084
阅读全文 →
PubMedMedComm2026-11-18

Advances in 3D-Printed Scaffolds for Regenerative Therapy.

Song Shitang S, Guo Ningyi N, Wang Siqi S, Liu Wei W et al.

Three-dimensional (3D) printing enables precise control over scaffold geometry, porosity, material distribution, and spatial delivery of cells and bioactive cues. However, features intended to improve biological fidelity often increase manufacturing complexity, quality-control demands, and regulatory burden. This review evaluates 3D-printed scaffolds for regenerative therapy using a design-to-translation framework. We compare acellular printing, cell-laden bioprinting, and hybrid fabrication, and examine how material composition, architecture, mechanics, degradation, gradients, vascularization, innervation, and immune integration determine performance. Evidence is synthesized across cartilage and osteochondral repair, bone, skin, neural, and spinal cord repair, skeletal muscle and soft tissues, and cardiac and vascular regeneration. Current evidence places acellular or minimally bioactive patient-specific scaffolds closest to clinical adoption, particularly when anatomical conformity and structural support are the dominant requirements. By contrast, living bioprinted constructs remain limited by reproducibility, tissue maturation, safety, storage, release testing, and scalable manufacturing. We therefore propose that scaffold complexity should be matched to a defined biological bottleneck and assessed using endpoints that capture functional repair, interface stability, host integration, and long-term performance. This framework shifts evaluation beyond printability toward regenerative benefit, manufacturability, and clinically reproducible design.

PMID 43048038
阅读全文 →
PubMedVideo journal of sports medicine2026-11-18

Hip Capsular Reconstruction Utilizing Acellular Dermal Allograft for Capsular Insufficiency: A Revision Hip Arthroscopy Technique.

Brinkman Joseph C JC, Monty Ty L TL, Sparks Chandler A CA, Kunze Kyle N KN et al.

Hip capsule integrity is essential for optimal outcomes after hip arthroscopy. Iatrogenic capsular insufficiency is a recognized cause of postoperative microinstability or macroinstability and a common indication for revision hip arthroscopy. Capsular reconstruction with allograft augmentation is a technique used to address capsular deficiency in this setting. This technique is indicated for patients with symptomatic instability and confirmed capsular insufficiency. Clinical suspicion based on history and physical examination should be confirmed with advanced imaging. Symptomatic, large capsular defects identified on imaging are appropriate for allograft augmentation. Suture anchors are placed at the 12 and 2 o'clock positions along the acetabular rim, and suture tapes are passed through the proximal and distal capsular remnants to span the defect. An acellular dermal allograft, sized approximately 20% larger than the measured defect, is prepared ex vivo with peripheral sutures to create a shuttling construct. The graft is introduced arthroscopically into the joint, positioned over the defect as a patch, and secured to the native capsule with arthroscopic knots and additional peripheral fixation to restore capsular integrity. Biomechanical studies have demonstrated restoration of capsular stability following allograft reconstruction. Clinical outcomes in the revision setting have shown improved stability and patient-reported outcomes, with relatively low reported failure rates. Failure to restore capsular integrity during hip arthroscopy may contribute to postoperative instability, pain, and functional limitations. Current evidence suggests that capsular reconstruction can reestablish stability and provide meaningful clinical improvement in appropriately selected patients. Acellular dermal allograft reconstruction represents a viable technique for addressing large capsular defects in revision hip arthroscopy. The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.

PMID 43048644
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Acellular Dermal Matrices in Aesthetic Surgery: Clinical Applications.

Sydorchuk Olena O, Nguyen Andrea T AT, Yi Kyu-Ho KH

Acellular dermal matrices (ADMs) are decellularized extracellular matrix scaffolds derived from human or animal dermis and are increasingly used as adjuncts in aesthetic and cosmetic plastic surgery. This narrative review summarizes the mechanisms, clinical applications, safety considerations, and evidence limitations of ADM use in aesthetic surgery. A narrative literature review was conducted using PubMed/MEDLINE and reference screening to identify clinical reports, comparative studies, systematic reviews, society assessments, animal studies, and histologic studies relevant to ADM incorporation, remodeling, capsule formation, and aesthetic outcomes. ADM applications in aesthetic surgery include facial contour camouflage, rhinoplasty soft-tissue augmentation, lower eyelid spacer grafting, implant pocket control, implant camouflage, and selected management of capsular contracture in cosmetic breast surgery. The quality of evidence varies by indication. Facial and rhinoplasty applications are supported mainly by small case series, lower eyelid spacer grafting has comparative evidence including a prospective randomized study, and cosmetic breast applications are supported primarily by retrospective cohorts and large clinical series. Reported complications include seroma, infection, delayed integration, graft contraction, contour irregularity, extrusion, and cost-related limitations. ADMs may be useful adjuncts in selected aesthetic surgery patients when applied according to a clear anatomic or biologic rationale. However, stronger long-term comparative studies, standardized outcomes, and cost-benefit analyses are still needed.

PMID 43047111
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多acellular pertussis vaccine